Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Nov 20 2020

Full Issue

Report: EU Gets Lower Price Than U.S. For Pfizer, CureVac Vaccines

The report from Reuters says that the lower price reflects the financial support given by the European Union to BioNTech for the drug’s development. News is on Mexico and Serbia, as well.

Reuters: Exclusive: EU Could Pay Over $10 Billion For Pfizer And CureVac Vaccines - Source

The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters. The bloc has agreed to pay 15.50 euros ($18.34) per dose for the COVID-19 vaccine candidate being developed by Pfizer and BioNTech, according to the official. (Guarascio, 11/20)

AP: Mexico Tops 100,000 COVID-19 Deaths, 4th Country To Do So

Mexico passed the 100,000 mark in COVID-19 deaths, becoming only the fourth country to do so amid concerns about the lingering physical and psychological scars on survivors. José Luis Alomía Zegarra, Mexico’s director of epidemiology, announced late Thursday that Mexico had 100,104 confirmed COVID-19 deaths, behind only the United States, Brazil and India. (Delgado, 11/20)

Reuters: Patriarch Of Serbian Orthodox Church Dies Of COVID-19 

Patriarch Irinej, the head of the Serbian Orthodox Church, has died after contracting COVID-19, President Aleksandar Vucic said on Friday. Church bells tolled in Belgrade and many people flocked to the capital’s main St Sava cathedral to mark his death at the age of 90, a decade after becoming Patriarch. (Vasovic, 11/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF